Trials / Unknown
UnknownNCT00785317
Effects of Estradiol on Menopausal Breast
Effects of Oral 1 mg Oestradiol (E2)/ 2 mg of Drospirenone (DRSP) Compared to Oral 1 mg of Oestradiol (E2)/ 0.5 mg Noresthisterone Acetate (NETA)on the Postmenopausal Breast; a Double Blind Randomized Prospective Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Karolinska Institutet · Academic / Other
- Sex
- Female
- Age
- 50 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effects on breast in postmenopausal women randomized to either oestradiol in combination with DRSP or E2 in combination with NETA during six months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Angemin vs Activelle | 1 mg of oral oestradiol (E2) in continuous combination with 2 mg of DRSP or 1 mg of oral E2 in continuous combination with 0.5 mg of NETA during six months. |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-10-01
- Completion
- 2010-04-01
- First posted
- 2008-11-05
- Last updated
- 2008-11-05
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00785317. Inclusion in this directory is not an endorsement.